Chemical, pharmacological, and metabolic considerations on thiothixene. Introduction: chemical and pharmacological relationship of thioxanthenes and phenothiazines.
D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D000932:Antiemetics / Q000494:pharmacology; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001833:Body Temperature Regulation / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D002749:Chlorprothixene / Q000494:pharmacology; D003006:Clopenthixol / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009132:Muscles / Q000187:drug effects; D010640:Phenothiazines / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects; D013329:Structure-Activity Relationship; D013565:Sympatholytics / Q000494:pharmacology; D013888:Thiothixene / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D013892:Thioxanthenes / Q000494:pharmacology
D000928:Antidepressive Agents; D000932:Antiemetics; D006993:Hypnotics and Sedatives; D010640:Phenothiazines; D013565:Sympatholytics; D013892:Thioxanthenes; D013888:Thiothixene; D003006:Clopenthixol; D002749:Chlorprothixene; D000661:Amphetamine; D004298:Dopamine